Schreibelt, Gerty <br/><br/>
Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  05 2016 
 - 2155-66 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-15-2205  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antigens, Neoplasm--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cancer Vaccines--immunology<br/>Chemokine CCL4--immunology<br/>Dendritic Cells--immunology<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Interferon-gamma--immunology<br/>Lysosomal-Associated Membrane Protein 1--immunology<br/>Male<br/>Melanoma--immunology<br/>Middle Aged<br/>Monocytes--immunology<br/>Neoplasm Metastasis--immunology<br/>Tumor Necrosis Factor-alpha--immunology<br/>Vaccination--methods